Glycomet Tablets: Strengths, Pack Sizes and Prices

Glycomet is an oral metformin tablet, and we list it in two strengths, 250 mg and 500 mg, across a range of pack sizes. This guide covers the exact choices available in our catalogue, how pack size affects unit value, and the practical points worth weighing before you settle on an order.

Glycomet price and choice overview

The first decision is the strength that matches the treatment plan set by your prescriber. Pack quantity comes next: it affects the total amount paid, the price per tablet, how often you may need to reorder, and how much medicine you need to store. A lower unit price can be useful, but only when the strength and quantity are suitable for the dose you have actually been advised to take.

We offer Glycomet 250 mg tablets in packs of 30, 60, 90 and 180 tablets. Our Glycomet 500 mg options contain 180, 270 or 360 tablets. These quantities are tablet counts rather than doses or days of treatment; the duration of a pack depends on the number of tablets in your individual daily regimen.

What package options and unit values do we offer?

Because metformin is commonly used as long-term treatment, pack size can have a meaningful effect on reorder frequency and price per tablet. The comparison below presents the exact total prices, unit values and relative savings for our three Glycomet 500 mg pack sizes, allowing you to compare the available figures directly.

As a general pattern in medicine packaging, a larger pack may have a lower price per tablet because packing and dispatch costs are spread over more units. The displayed comparison reflects our own current offer only; it does not rely on prices from other pharmacies or external discount schemes.

Unit value should be considered alongside expected use. A pack is not economical if the dose is likely to change, the tablets cannot be used before their printed expiry date, or the quantity exceeds the supply you and your prescriber have planned. Before selecting a larger pack, it is sensible to confirm that your regimen is stable and that you have suitable storage space.

Which strength and pack size suit your planned supply?

Choosing between 250 mg and 500 mg, and between a smaller or larger pack, is mainly a question of your prescribed dose and the period of supply you intend to hold. Metformin is often introduced at a lower dose and increased gradually to improve tolerability, so a strength that is appropriate during titration may not be the same one used after the regimen has stabilised.

• Prescribed daily dose: choose the strength that allows you to follow the directions from your prescriber without changing the number of tablets on your own.
• Stage of treatment: a smaller pack may be more practical while treatment is being started or reviewed, whereas a larger quantity may suit a stable long-term regimen when that supply has been planned.
• Storage and expiry: larger packs require more room and should still be used within the expiry date printed on the packaging.
• Budget and reorder frequency: a larger pack may reduce unit cost and the need to reorder, but it requires a higher payment upfront and commits you to one strength for longer.

The table summarises how the available strengths and quantities relate to these practical considerations, separately from the exact prices shown in the package-value comparison.

Do not assume that two 250 mg tablets can always replace one 500 mg tablet, or alter the tablet count to obtain a lower price, without checking the directions for your medicine. The prescribed total dose, dosing schedule and formulation all matter when deciding how tablets should be taken.

Glycomet, generic metformin and other brands

Glycomet is a branded metformin tablet rather than a different antidiabetic medicine. Generic metformin tablets and brands such as Glucophage contain the same active ingredient, but manufacturers, excipients, tablet appearance and available formulations may differ. Products containing the same dose and release type are expected to provide comparable glucose-lowering effects, although an individual may notice differences in swallowing or gastrointestinal tolerability.

When comparing options, check the active ingredient, strength, dosage form and release type rather than relying on the brand name alone. In particular, a standard tablet should not be treated as interchangeable with a modified-release product unless a prescriber or pharmacist confirms the change. Our offer described here is specifically for Glycomet oral tablets in the listed 250 mg and 500 mg strengths.

Established use of metformin

Metformin belongs to the biguanide class of antidiabetic medicines and is an established first-line treatment for type 2 diabetes in adults, usually alongside changes to diet and physical activity. It helps improve blood glucose control when lifestyle measures alone are not sufficient. It may be used by itself or with other glucose-lowering medicines, including insulin.

Metformin is also used under specialist supervision in some cases of gestational diabetes and for people with pre-existing type 2 diabetes during pregnancy. Tablets are established for children aged 10 years and over with age-appropriate dosing and monitoring, although evidence in younger children within that age range is more limited. Metformin does not treat type 1 diabetes by itself and is not a substitute for insulin when insulin is required.

Response is assessed through blood glucose results and longer-term measures such as HbA1c rather than by whether a tablet produces a noticeable sensation. Regular reviews also give the prescriber an opportunity to check kidney function, tolerability, adherence and whether the dose remains appropriate.

Metformin action and practical administration

Metformin lowers blood glucose mainly by reducing glucose production in the liver and improving the body's sensitivity to its own insulin. It does not principally work by stimulating the pancreas to release more insulin, which is why metformin alone has a low risk of causing hypoglycaemia.

Glycomet tablets are generally taken with or just after food to reduce nausea, diarrhoea and other gastrointestinal effects. The dose is commonly increased gradually over several weeks under a prescriber's guidance until an effective and tolerable regimen is reached. Follow the directions supplied for your own dose, take tablets at consistent times, and do not double a dose to make up for one you have missed.

The glucose-lowering effect develops over days, with the full effect of a dose adjustment assessed over a longer period through ongoing monitoring. Continue taking metformin as directed even when you do not feel different, unless a healthcare professional advises you to pause or stop it.

Safety, monitoring and interactions

Metformin is generally well tolerated, but its safe use depends on appropriate monitoring and awareness of situations that can increase risk:

• Digestive effects: nausea, diarrhoea, abdominal discomfort, reduced appetite and a metallic taste are common when treatment begins. Taking tablets with food and increasing the dose gradually may help.
• Kidney function: renal function is normally checked before treatment and at least annually afterwards, or more often when kidney function is reduced or could deteriorate.
• Lactic acidosis: this is a very rare but serious adverse effect. Seek urgent medical attention for symptoms such as severe weakness, vomiting, abdominal pain, breathing difficulty, muscle cramps or feeling unusually cold, particularly during severe illness or dehydration.
• Vitamin B12: longer-term or higher-dose metformin use can reduce vitamin B12 levels. Testing may be appropriate if anaemia, marked tiredness, a sore red tongue, pins and needles or other symptoms of deficiency develop.
• Low blood glucose: hypoglycaemia is not typical with metformin alone but can occur when it is combined with insulin or a sulfonylurea. This can affect driving and the safe use of machinery.

Metformin is contraindicated in diabetic ketoacidosis or diabetic pre-coma and should not be used by anyone with hypersensitivity to metformin or another tablet ingredient. Acute illness involving severe vomiting, diarrhoea, fever, dehydration, serious infection, reduced oxygen supply, or worsening heart, liver or kidney function may require temporary interruption under medical advice.

Iodinated contrast media can affect kidney function, so tell the prescriber or radiology team that you take metformin before a scan involving contrast. Metformin may also need to be paused around some operations. Alcohol excess increases the risk of lactic acidosis, while medicines that alter kidney function or blood glucose control can change monitoring needs. Provide a complete list of medicines and supplements whenever treatment is reviewed.

Metformin passes into breast milk in very small amounts and is generally considered compatible with breastfeeding for a healthy full-term infant. Use during pregnancy requires specialist supervision and closer glucose monitoring because metformin crosses the placenta and insulin may need to be added or substituted.

Do you need a prescription to order Glycomet from us?

Metformin tablets are classified as a prescription-only medicine in the United Kingdom. This classification is separate from our product-specific ordering policy. Within our ordering process, we do not require you to submit a prescription to place an order for Glycomet, so you can select a listed strength and pack size and complete checkout without uploading one first.

Our ordering policy does not change the medicine's prescription classification or replace appropriate clinical care. Metformin dosing, titration and kidney monitoring should still be overseen by a suitable healthcare professional. Our pharmacist-supported team is available if you have a question about the product or your order, but urgent symptoms and decisions to start, stop or change treatment require direct medical advice.

Ordering, delivery and receiving Glycomet

Once you have selected a strength and pack size, our checkout confirms the exact option before payment. We have supported UK customers since 2018, and our support team is available 24/7 by email or online chat. A pharmacist is also available to answer product and order-related questions.

After dispatch, we pack the tablets securely for transit. On receipt, Glycomet should be stored at 20°C to 25°C in its original, tightly closed container, protected from light and moisture. Brief temperature excursions between 15°C and 30°C are permitted.

Use this short checklist when your pack arrives:

• Check that the product name, strength and tablet quantity match the option you selected.
• Inspect the packaging and contact our support team if it appears damaged or tampered with.
• Check the expiry date and make sure the planned supply can be used before it expires.
• Keep the tablets in their original labelled container and away from damp areas such as bathroom cabinets.
• Store all medicines out of the sight and reach of children.

Balancing package value with your treatment plan

The most economical Glycomet pack per tablet is only part of the decision. A larger 500 mg pack may reduce unit cost and reorder frequency, but it represents good value only if it matches the strength, dose and treatment duration planned for you. A smaller quantity may be the more practical choice while a dose is changing, side effects are being assessed, or a review is due.

Compare the available package figures, then confirm the correct strength and estimate how long the quantity will last at your prescribed tablet count. Also consider storage space, expiry, upfront cost and the likelihood of a dose adjustment. Matching pack size to a stable metformin regimen is the clearest way to combine useful unit value with a supply you can realistically use. For broader treatment navigation, visit our Diabetes category.